chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt c/o numbness and tingling in fingers of both hands. BP 155/97 O2 sat 98% room air pulse 68 Report BP 139/79 P77 pulse O2 100%
Vertigo - I felt dizzy upon waking and the world seemed to be spinning.  I had no other symptoms (no fever).  It got a bit better during the day, then recurred the next morning.
This spontaneous case was reported by a consumer and describes the occurrence of SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 11J20A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis and Blood pressure.Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away). The patient was treated with AMOXICILLIN for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at a dose of dose pack. At the time of the report, SECRETION DISCHARGE (Thick mucus draining on the back of their throat/it was terrible/never truly went away) had not resolved. Concomitant medications include arthritis medication and blood pressure medication.Treatment to the events given as common allergy medication.A day or 2 after the second dose of the Moderna vaccine noticed thick mucus draining on the back of their throats For patient one it became not quite as thick and not quite as much. For patient 2 it never got better, it was always thick. This case was linked to MOD-2021-388670 (Patient Link).
So far patient has not reported any adverse events.   When  we started to administer the second dose from the vial for another patient we realized we only had 0.5ml left in the vial.   We did add diluent but we must not have added the full 1.8ml.
Information has been received from a licensed visiting nurse concerning a female in her 40s who on Sept 21 2004 was vaccinated in the left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 649693/0486P). The nurse reported that 5 hours post vaccination the patient developed a high fever and angry, red, painful, swollen left arm. the patient was treated with diphenhydramine HCL. On follow up, the patient still had the red. sore arm. The patient stated that the arm felt heavy, almost like after a diphtheria or tetanus shot. The nurse requested that a lot check be performed on lot 649693/0486P. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. The nurse reported another patient who had similar symptoms post vaccination with pneumococcal 23v polysaccharide vaccine (lot 649693/0486P) (WAES0409USA02062). Additional information has been requested.
Patient reported 20 hours post vaccination a 101 - 103 degree F fever that lasted until 36 hours post vaccine after a few hours  experienced chills, aches, fatigue, and sore arm that resolved after 36 hours also.
HBP calling to report AE for improperly stored VARIVAX administered to a patient.; Spontaneous information has been received from a physician via office manager, regarding a female patient of unknown age. Information regarding her medical history, concurrent conditions and concomitant medications was not provided.   On 24-AUG-2023, the patient was vaccinated with an improperly stored (product storage error) varicella virus vaccine live (Oka/Merck) (VARIVAX III) (reported as varicella zoster vaccine live) (lot# X007373 valid, expiration date on 12-MAR-2025) with a previous temperature excursion of 9.5 degree Fahrenheit for 2 hours and 10 minutes and a temperature of 6.9 degree Fahrenheit with a time frame of 1 hour and 30 minutes. No side effects reported.
CHEST PAIN; This spontaneous report received from a patient concerned a 19 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, shellfish allergy, no alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug use. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 03-MAY-2021 12:50 for prophylactic vaccination. No concomitant medications were reported. On 03-MAY-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 03-MAY-2021 22:00, the subject experienced chest pain. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from chest pain. This report was non-serious.
Dry Heaving, Full Seizure activity for approximately 1 minute or less. Patient has no History of Seizure's.
T104 7JUL92 PM-hospitalized 7JUL92-8JUL92 temp still 101.2 w/APAP; d/c home 9JUL92;
Chills; This is a spontaneous report received from a contactable reporter(s) (Nurse), Program ID:   A 33-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. The following information was reported: CHILLS (non-serious), outcome "unknown".  Additional information: It was reported the "He got the 1st 2 like a few months after they became available to the general public beyond the front-line workers and he was fine after those, he had the usually expected like chills. The last one he got a few months ago like 3 months ago for the booster". No Prior Vaccinations (within 4 weeks). No Family Medical History Relevant to Adverse Events.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : PFIZER INC-202201368953 same patient/drug, different AE/ dose; PFIZER INC-202201369624 same patient/drug/AE, different dose.
Patient had large palm sized red mark circling injection site. It had been 2 days after injection and the area had gotten worse and warm. She also had a huge red ring around her armpit that had come right away, but had gone down some on day 2. Husband is a retired PA and was monitoring it from home.
Patient reported felling light headed and dizzy after vaccination. Immunizer questioned patient as to last known meal. Patient had not eaten breakfast. Given orange juice and a light snack. Side effects subsided within 20 minutes and patient was able to return to work. Immunization given under emergency protocol. Patient is a healthcare worker in a long term care facility. Was able to resume normal duties after being monitored by immunizing staff.
4 days after the second dose of the vaccine I developed Tinnitus.  I contacted the pharmacy where I got  it and reported this.  The Pharmacist indicated she did see this has been reported as a rare side effect and thought I should report this.  The tinnitus has been persistent since.
Brain headache; Chills; This is a spontaneous report received from a contactable consumer (Parent).   A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jun2021 (Batch/Lot Number: Unknown) as 1st dose, singled dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 08Jun2021, the patient experienced brain headache and chills. The outcome of events was unknown.   Information about batch/lot no has been requested.
Loss of appetite; Cannot walk; Cannot urinate; Lost all energy; Chills; Vomitting; Ttired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), GAIT DISTURBANCE (Cannot walk), DYSURIA (Cannot urinate), ASTHENIA (Lost all energy) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite), GAIT DISTURBANCE (Cannot walk), DYSURIA (Cannot urinate), ASTHENIA (Lost all energy), CHILLS (Chills), VOMITING (Vomitting) and FATIGUE (Ttired). At the time of the report, DECREASED APPETITE (Loss of appetite), GAIT DISTURBANCE (Cannot walk), DYSURIA (Cannot urinate), ASTHENIA (Lost all energy), CHILLS (Chills), VOMITING (Vomitting) and FATIGUE (Ttired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
patient cousin stated patient was lethargic, unresponsive and had a fever of 102 degrees hours after receiving the vaccine.  They took him to the ER by ambulance.  The hospital treated the patient and released the same day.
This spontaneous report was received from a male physician of unknown age referring to himself. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patient received one dose of ZOSTAVAX (lot number, expiration date and route of administration were not reported). On an unspecified date, the patient received a booster of ZOSTAVAX (lot number, expiration date and route of administration were not reported) because his significant other had developed active shingles. The patient stated "he did not feel that his prior ZOSTAVAX dose would provided him with proper immunity". The outcome of the events was unknown. This is one of the several reports received from the same source. Additional information has been requested.
1 minutes post inoculation: Tachycardia with HR 160BPM & left arm swelling.  Pt states feeling "generally unwell."  Anxious mood. Meds administered during ED visit: Sodium Chloride 0.9% bolus 1L IV; famotidine 20mg IV; diphenhydramine 50mg IV During ED visit VS: BP 123/76, Temp 98.2F oral, HR 84, RR 16, SpO2 100% on RA.
Post vax, the pt developed erythematous maculopapular rash on trunk and extremities with warmth to the touch. Duration 3-4 days. Treatment Benadryl.
Fever started on 6/14/70. On 6/15/70, at 09:00, went into convulsions. Gave aspirin and cool baths, per doctor's advice. About 13:00, she had seizures again. Fever was 104F. Drove to doctor's office and he gave her a shot, seizures didn't stop. Drove to hospital and she was admitted. She got another shot about 19:00. Treated with phenobarbitol and Gravol (to settle stomach), aspirin and antibiotics. Pt had seizures, vomiting, kidney infection, rash and blisters on body. Seizures recurred, got worse in time. May 1978 started Dilantin, September 1980, started Tegretol and seizures continue. Our daughter's brain has deteriorated, especially memory and personality. The follow up states "I reported the adverse effects our daughter suffered, to you 8/20/00. You can add the enclosed info to our daughter's file. This is what the measles vaccination at age 16 months has led to. It was Lirugen as I have informed you before. Lifelong seizures is not the only complication. For 21 years, from 1980-2001 (starting at age 11 yrs) she was taking Tegretol to control the seizures, which can affect the white blood cell count and bone marrow (multiple myeloma) and spread to the bones (bone cancer). This has happened. This year our daughter was scheduled from March to August for infusions to treat her condition, because her bone pain was so severe. For the last year she was put on new anticonvulsants: Keppra and Lamictal. Even these could not improve and control her seizures. So, as a last resort, she underwent the Vagus nerve stimulator implantation. She is so angry, frustrated and hopeless by what a "simple" measles vaccination has done to her life, evident in the enclosed VNS description. And how do you think we as parents feel?!
Approx 3 min post inject neonate turned ashen pale, 0 respirations, HR normal-responded to stimulation & color returned-observed in ofc for 1 hr.
13JAN92 pt recvd Engerix-B vax & 15JAN92 inject site became swollen, bruised (3 mc). nodule very pruritic; denies systemic reaction; tx w/DPH & Calydryl lotion;
Had vaccine 7/18. Had blood in my stool Monday and Tuesday 7/19-7/20. Woke up with more RUQ abdominal pain on 7/21.
Pt developed fever to 101.3 which lasted 36 hrs and a rash from head to toe, even on face, soles of feet and palms of hands. Rash had small, raised bumps, and it was still bad on his back and bottom 1 week later. No scratching was noted. The rash is slowly improving and the pt is acting well.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 14:00 as dose 4 (booster), single (Lot number: GH9703) at the age of 67 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: EL9262), on 03Mar2022 as dose 2, single (Lot number: EN 6201) and on 01Dec2021 as dose 3 (booster), single (Lot number: 330268D) for covid-19 immunisation. The patient's relevant medical history included: "Several arterial aneurysms" (unspecified if ongoing), notes: Several arterial aneurysms; "high blood pressure" (unspecified if ongoing), notes: high blood pressure; "depression" (unspecified if ongoing); "Penicillin Allergy" (unspecified if ongoing); "Sulfa Drugs allergy" (unspecified if ongoing), notes: Sulfa Drugs allergy. Concomitant medication(s) included: AMLODIPINE BESYLATE, stop date: 05Oct2022; LAMOTRIGINE, stop date: 05Oct2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Oct2022) negative, notes: one day after completing course of Paxlovid; (13Oct2022) positive, notes: tested positive again two days later. Therapeutic measures were taken as a result of vaccination failure, covid-19 Paxlovid treatment was started.  Follow up information has been requested.
5-10 minutes developed anaphylaxis: Eye wateriness, puffiness. Abdominal discomfort. Hives. Swollen lips/tongue. Tachycardia. Given epinephrine and BENADRYL.
Narrative:  Patient reports "Arm swelled up to size of egg" after administration of a COVID vaccination. Patient previously reported no issues with vaccine series. As patient had not received a dose of vaccine in 12 months, unclear if patient received a booster at outside facility undocumented or if reaction to 2nd dose in 2021 was incorrectly documented at previous visit.
This spontaneous report was received from a licensed practical nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 14-OCT-2016, the patient was vaccinated with improperly stored (16.2 C for 8 hours) doses of M-M-R II (lot # M016234, expiry date 31-MAR-2018, dose, dose number, vaccination site, route unspecified). There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient underwent APR with end colostomy creation, mobilization of splenic flexure and removal of perineal nodule on 11/30/2021 for rectal carcinoma. Treated in hospital and discharged. Hospital admission within 6 weeks of receiving the COVID vaccine.
Dose #1 - bleeding from ears and sudden severe tinnitus (ongoing) - examined by doctor and ENT doctor at Health System Dose #2 - worsening tinnitus (ongoing) Dose #3 - severe, excruciating, life changing worsening of tinnitus (seeking medical treatment)
Myalgia, Diarrhea, Arm pain first, then 1/9 body aches and chills; the 1/10 diarrhea; all symptoms resolved. Narrative:
Information has been received from a physician concerning a 14 year old female patient with no drug reactions or allergies who on 29-APR-2010 was vaccinated intramuscularly with a first dose of GARDASIL. On 29-APR-2010 the patient developed itching all over her body after receiving her first dose and only dose of GARDASIL. The patient sought unspecified medical attention and was given BENADRYL via intramuscular injection. No laboratory diagnostic studies were performed. On 29-APR-2010, the patient had fully recovered from this event. "The patient was given BENADRYL via intramuscular injection" was considered to be an other important medical event by the physician. Additional information has been requested.
This spontaneous report as received from a physician refers to a 87 years old male patient who an unspecified date a couple of years ago, was vaccinated with a single dose of 0.65 ml subcutaneous injection of ZOSTAVAX (lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The patient developed a case of shingles a couple of years later on 02-NOV-2011. The patient sought medical attention. The patient was prescribed with VALTREX for adverse event. On an unspecified date, the patient recovered from adverse event. The relatedness for the adverse event was unknown for ZOSTAVAX. Additional information has been requested.
Fatigue  Chills Body Aches  Itchy swollen rash on arm
3/25 11 pm. Stiff neck, mild upper back pain, headache.  Took ibuprofen and went to bed soon after.  3/26 8 am Awake, symptoms mild. Around 11 am symptoms worsen with mild general joint pain, muscle pain, fatigue, headache. Symptoms improve around 4pm and resolve completely by around 8pm. Essentially felt 'flu like' symptoms (no respiratory signs), not unexpected for this vaccine, but was surprised by how bad the following day was.  Did not check for fever.
Child became limp. Was taken to ER. Some seizure-like activity noted. Transferred to another hospital. CXR suggests pneumonia. CT and blood work WNL. EEG result pending. Expected to be discharged today (6-23-10). Will followup with DR. in 1 week.
Patient reported seeing pitch black around 10 minutes after vaccine administration. Patient reports she almost fell but caught herself on the shopping cart. When patient came to us, she spoke normally and was able to tell us what happened.
clinical rubeola w/fever, morbilliform, eruption, leukopenia & thrombocytopenia;
07/09/2022  She started with a fever that never got over 100.3. She was sneezing and complained of a headache. The next day she woke up with a sore throat. On 7/11/2022 She was complaining of chills and had a low-grade fever. I had her tested for COVID at a clinic which was positive. Later that day she developed a cough.  7/12/2022 She continued to have a cough and sore throat which lasted until 7/15/2022.  She has recovered, her cough is gone and she has no other symptoms.
After the vaccine I felt exhausted, fever, chills for 3 days.Then I started exp really bad allergies this season. At the end of May I felt horrible one morning got up 2:00am woke up with hives and vomiting. I went to ER had difficulty breathing kind of anaphylactic reaction. I was given Prednisone for 3 days. Then discharged still had hives. I went back to my doctor given another dosage of Prednisone. The only time I had ever had hives was as a child when given Penicillin. As of now Im still super itchy take Pepcid and Zyrtec daily.If I forget to take my medications it I develop red spots on my arms and feet. My doctor has me taking an inhaler think the breathing problems might go into my lungs.
About 5 minutes after injection, individual reported that she began to feel faint, "hot", and dizzy. Individual then had an episode of syncope. She was diaphoretic, muscles were contracted, breathing became labored, and patient urinated herself.  Individual was unconscious for 2 minutes. MS services arrived just after individual regained consciousness. Upon assessment, all vital signs were within normal limits and patient reported that she no longer felt anything abnormal. Patient denied being seen by a doctor.
Approx 10 minutes after injection patient fainted. No allergic symptoms were noted. Pt was very nervous and had not eaten prior to injections.
Was already hospitalized due to being ill when given vaccination. I had a little tingling after injection .
MOM STATES THAT HER EYES ROLLED UP AND SHE FELL TO THE FLOOR. MOM WAS AFRAID SHE'D HAD HER FIRST SEIZURE. I RESPONDED QUICKLY TO THE REQUEST FOR HELP. WHEN I ARRIVED, PT WAS STANDING WITH ASSISTANCE, SHE WAS RED IN THE FACE WITH TEARS, SHE WAS SPEAKING CLEARLY AND RESPONSIVE. BBECAUSE SHE WAS SHOOK UP BUT LUCID, SHE DID NOT APPEAR LIKE SHE NEEDED TO LIE DOWN. WE WENT TO A SITTING AREA. SHE CONTINUED TO CRY AND ANSWER QUESTIONS. SHE DID NOT INJURE HERSELF DURING THE FALL. THE FAMILY STATES SHE FELL ON HER BOTTOM. I MONITERRED THE PATIENT FOR ABOUT 5-10 MINUTES WITH THE FAMILY. SH APPEARED TO HAVE RECOVERRED. I ASKKED MOM TO CONITNUE TO MONITOR HER FOR VOMITTING, HEADACHE, STOMACH UPSET AND TAKE ANNY SYMPTOMS SERIOUSLY. I REASSURED MOM THAT A SIEZURE WAS UNLIKELY AND FAINTING WAS MOST LIKELY WHAT TOOK PLACE.    I CALLED MOM ABOUT AN HOUR LATER, SHE STATES THAT PATIENT HAD RECOVERRED AND IS ACTING NORMAL, SHE IS STILL MONITORING HER
Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic rhinitis (can never smell anything).    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine). On 26-Apr-2021, THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine) had resolved.            No concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-455408, MOD-2022-455403 (Patient Link).
patient had a fever for 24 hours, increased heartrate for 24 hours and a tingling that started around the injection site and traveled to his elbow and down to his fingers.  He also had a tingling on his left leg.  This tingling started about 24 hours after the shot and is still continuing to occur.  The tingling is only on his left side which is the side of his body that received the shot.